Efficacy and safety of pomegranate medicinal products for cancer

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Vlachojannis, Christian ^a   Zimmermann, Benno F ^b,c   Chrubasik Hausmann, Sigrun ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Institut Prof Dr Georg Kurz GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; ANTINEOPLASTIC AGENT; ELLAGIC ACID; LIVER ENZYME; PLANT MEDICINAL PRODUCT; POMEGRANATE EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG SYNTHESIS; ENZYME ACTIVATION; FLOWER; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; OTOTOXICITY; POMEGRANATE; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCTIVE TOXICITY; REVIEW; SYSTEMATIC REVIEW;

EID: 84925433258     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/258598     Document Type: Review

References (128)

1. V. M. Adhami, N. Khan, and H. Mukhtar, "Cancer chemoprevention by pomegranate: laboratory and clinical evidence, " Nutrition and Cancer, vol. 61, no. 6, pp. 811815, 2009.
2. M. Toi, H. Bando, C. Ramachandran et al. , "Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo" Angiogenesis, vol. 6, no. 2, pp. 121-128, 2003.
3. S. Koyama, L. J. Cobb, H. H. Mehta et al. , "Pomegranate extract induces apoptosis in human prostate cancer cells bymodulation of the IGF-IGFBP axis" GrowthHormone and IGF Research, vol. 20, no. 1, pp. 55-62, 2010.
4. M. B. Rettig, D. Heber, J. An et al. , "Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism" Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2662-2671, 2008.
5. A. Malik, F. Afaq, S. Sarfaraz, V. M. Adhami, D. N. Syed, and H. Mukhtar, "Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer" Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 41, pp. 14813-14818, 2005.
6. A. Bishayee, R. J. Thoppil, A. S. Darvesh, V. Ohanyan, J. G. Meszaros, and D. Bhatia, "Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis" Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 178-187, 2013.
7. P. Filannino, L. Azzi, I. Cavoski et al. , "Exploitation of the health-promoting and sensory properties of organic pomegranate (Punica granatum L. ) juice through lactic acid fermentation" International Journal of Food Microbiology, vol. 163, no. 2-3, pp. 184-192, 2013.
8. N. D. Kim, R. Mehta, W. Yu et al. , "Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer" Breast Cancer Research and Treatment, vol. 71, no. 3, pp. 203-217, 2002.
9. R. Mehta and E. P. Lansky, "Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture" European Journal of Cancer Prevention, vol. 13, no. 4, pp. 345-348, 2004.
10. F. Aqil, R. Munagala, M. V. Vadhanam et al. , "Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk" Food Research International, vol. 49, no. 1, pp. 345-353, 2012.
11. M. Larrosa, F. A. Tomas-Barberan, and J. C. Espin, "The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using themitochondrial pathway" Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 611-625, 2006.
12. C. Palmieri, D. K. Patten, A. Januszewski, G. Zucchini, and S. J. Howell, "Breast cancer: current and future endocrine therapies" Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 695-723, 2014.
13. S. Banerjee, S. Kambhampati, I. Haque, and S. K. Banerjee, "Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells" Journal of Cell Communication and Signaling, vol. 5, no. 4, pp. 317-324, 2011.
14. M. Y. Hong, N. P. Seeram, andD. Heber, "Pomegranatepolyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor" Journal of Nutritional Biochemistry, vol. 19, no. 12, pp. 848-855, 2008.
15. P. Pitchakarn, T. Chewonarin, K. Ogawa et al. , "Ellagic acid inhibits migration and invasion by prostate cancer cell lines" Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 2859-2863, 2013.
16. M. Albrecht, W. Jiang, J. Kumi-Diaka et al. , "Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells" Journal of Medicinal Food, vol. 7, no. 3, pp. 274-283, 2004.
17. N. P. Seeram, L. S. Adams, S. M. Henning et al. , "In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice" Journal of Nutritional Biochemistry, vol. 16, no. 6, pp. 360-367, 2005.
18. M. R. Sartippour, N. P. Seeram, J. Y. Rao et al. , "Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo" International Journal of Oncology, vol. 32, no. 2, pp. 475-480, 2008.
19. A. Malik and H. Mukhtar, "Prostate cancer prevention through pomegranate fruit" Cell Cycle, vol. 5, no. 4, pp. 371-373, 2006.
20. N. P. Seeram, W. J. Aronson, Y. Zhang et al. , "Pomegranate ellagitannin-derivedmetabolites inhibit prostate cancer growth and localize to themouse prostate gland" Journal of Agricultural and Food Chemistry, vol. 55, no. 19, pp. 7732-7737, 2007.
21. L. S. Adams, Y. Zhang, N. P. Seeram, D. Heber, and S. Chen, "Pomegranate ellagitannin-derived compounds exhibit antiproferative and antiaromatase activity in breast cancer cells in vitro" Cancer Prevention Research, vol. 3, no. 1, pp. 108-113, 2010.
22. R. Vicinanza, Y. Zhang, S. M. Henning, and D. Heber, "Pomegranate juice metabolites, ellagic acid and urolithin a, synergistically inhibit androgen-independent prostate cancer cell growth via distinct effects on cell cycle control and apoptosis" Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 247504, 12 pages, 2013.
23. N. P. Seeram, Y. Zhang, R. McKeever et al. , "Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects" Journal of Medicinal Food, vol. 11, no. 2, pp. 390-394, 2008.
24. B. Cerda, J. C. Espin, S. Parra, P. Martinez, and F. A. Tomas-Barberan, "The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans" European Journal of Nutrition, vol. 43, no. 4, pp. 205-220, 2004.
25. R. Agosti, R. K. Duke, J. E. Chrubasik, and S. Chrubasik, "Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review" Phytomedicine, vol. 13, no. 9-10, pp. 743-746, 2006.
26. S. Chrubasik, C. Conradt, and B. D. Roufogalis, "Effectiveness of Harpagophytum extracts and clinical efficacy" Phytotherapy Research, vol. 18, no. 2, pp. 187-189, 2004.
27. J. J. Gagnier, S. Chrubasik, and E. Manheimer, "Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review" BMC Complementary and Alternative Medicine, vol. 4, article 13, 2004.
28. C. Chrubasik, R. K. Duke, and S. Chrubasik, "The evidence for clinical efficacy of rose hip and seed: a systematic review" Phytotherapy Research, vol. 20, no. 1, pp. 1-3, 2006.
29. J. E. Chrubasik, B. D. Roufogalis, H. Wagner, and S. A. Chrubasik, "A comprehensive review on nettle effect and efficacy profiles, part I: herba urticae" Phytomedicine, vol. 14, no. 6, pp. 423-435, 2007.
30. J. E. Chrubasik, B. D. Roufogalis, H. Wagner, and S. Chrubasik, "A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix" Phytomedicine, vol. 14, no. 7-8, pp. 568-579, 2007.
31. C. Chrubasik, B. D. Roufogalis, U. Muller-Ladner, and S. Chrubasik, "A systematic review on the Rosa canina effect and efficacy profiles" Phytotherapy Research, vol. 22, no. 6, pp. 725-733, 2008.
32. C. Chrubasik, G. Li, and S. Chrubasik, "The clinical effectiveness of chokeberry: a systematic review" Phytotherapy Research, vol. 24, no. 8, pp. 1107-1114, 2010.
33. J. E. Vlachojannis, M. Cameron, and S. Chrubasik, "Asystematic review on the effectiveness of willow bark for musculoskeletal pain" Phytotherapy Research, vol. 23, no. 7, pp. 897-900, 2009.
34. J. E. Vlachojannis, M. Cameron, and S. Chrubasik, "Asystematic review on the Sambuci fructus effect and efficacy profiles" Phytotherapy Research, vol. 24, no. 1, pp. 1-8, 2010.
35. J. E. Vlachojannis, M. Cameron, and S. Chrubasik, "Medicinal use of potato-derived products: a systematic review" Phytotherapy Research, vol. 24, no. 2, pp. 159-162, 2010.
36. A. J. Pantuck, J. T. Leppert, N. Zomorodian et al. , "Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer" Clinical Cancer Research, vol. 12, no. 13, pp. 4018-4026, 2006.
37. C. J. Paller, X. Ye, P. J. Wozniak et al. , "A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer" Prostate Cancer and Prostatic Diseases, vol. 16, no. 1, pp. 50-55, 2013.
38. S. J. Freedland, M. Carducci, N. Kroeger et al. , "A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy" Cancer Prevention Research, vol. 6, no. 10, pp. 1120-1127, 2013.
39. N. Kroeger, A. S. Belldegrun, and A. J. Pantuck, "Pomegranate extracts in the management of mens urologic health: Scientific rationale and preclinical and clinical data" Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 701434, 9 pages, 2013.
40. F. Stenner-Liewen, H. Liewen, R. Cathomas et al. , "Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer-results of a phase IIb randomized controlled trial" Journal of Cancer, vol. 4, no. 7, pp. 597-605, 2013.
41. S. Chrubasik-Hausmann, C. Vlachojannis, and B. Zimmermann, "Pomegranate juice and prostate cancer: importance of the characterisation of the active principle" Phytotherapy Research, 2014.
42. E. Davidson, J. Vlachojannis, M. Cameron, and S. Chrubasik, "Best available evidence in cochrane reviews on herbal medicine?" Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 163412, 7 pages, 2013.
43. S. Chrubasik-Hausmann, C. Vlachojannis, and B. F. Zimmermann, "Proanthocyanin content in cranberry CE medicinal products" Phytotherapy Research, 2014.
44. E. Davidson, B. F. Zimmermann, E. Jungfer, and S. Chrubasik-Hausmann, "Prevention of urinary tract infections with Vacciniumproducts" Phytotherapy Research, vol. 28, no. 3, pp. 465-470, 2014.
45. D. S. Ming, S. Pham, S. Deb et al. , "Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo" The Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 19-28, 2014.
46. Y. Wang, S. Zhang, S. Iqbal et al. , "Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy" Prostate, vol. 74, no. 5, pp. 497-508, 2014.
47. B. Cerda, J. J. Ceron, F. A. Tomas-Barberan, and J. C. Espin, "Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic" Journal ofAgricultural and Food Chemistry, vol. 51, no. 11, pp. 3493-3501, 2003.
48. C. Patel, P. Dadhaniya, L. Hingorani, and M. G. Soni, "Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies" Food and Chemical Toxicology, vol. 46, no. 8, pp. 2728-2735, 2008.
49. R. K. Kishore, D. Sudhakar, and P. R. Parthasarathy, "Embryo protective effect of pomegranate (Punica granatum L. ) fruit extract in adriamycin-induced oxidative stress" Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 106-111, 2009.
50. K. P. Leiva, J. Rubio, F. Peralta, and G. F. Gonzales, "Effect of Punica granatum (pomegranate) on sperm production in male rats treated with lead acetate" ToxicologyMechanisms and Methods, vol. 21, no. 6, pp. 495-502, 2011.
51. C. Fimognari, P. Sestili, M. Lenzi, A. Bucchini, G. Cantelli-Forti, and P. Hrelia, "RNA as a new target for toxic and protective agents"Mutation Research-Fundamental andMolecularMechanisms of Mutagenesis, vol. 648, no. 1-2, pp. 15-22, 2008.
52. E. M. Al-Olayan, M. F. El-Khadragy, D. M. Metwally, and A. E. Abdel Moneim, "Protective effects of pomegranate ( Punica granatum) juice on testes against carbon tetrachloride intoxication in rats" BMC Complementary and Alternative Medicine, vol. 14, article 164, 2014.
53. V. Sen, M. Bozkurt, S. Soker et al. , "The effects of pomegranate and carvacrol on methotrexate-induced bone marrow toxicity in rats" Clinical and Investigative Medicine, vol. 37, no. 2, pp. E93-E101, 2014.
54. F. Celik, C. Gocmez, M. Bozkurt et al. , "Neuroprotective effects of carvacrol and pomegranate against methotrexateinduced toxicity in rats" European Review for Medical and Pharmacological Sciences, vol. 17, no. 22, pp. 2988-2993, 2013.
55. A. E. Abdel Moneim, M. S. Othman, S. M. Mohmoud, and K. M. El-Deib, "Pomegranate peel attenuates aluminum-induced hepatorenal toxicity" Toxicology Mechanisms and Methods, vol. 23, no. 8, pp. 624-633, 2013.
56. D. Kumar, S. Singh, A. K. Singh, and S. I. Rizvi, "Pomegranate (Punica granatum) peel extract provides protection against mercuric chloride-induced oxidative stress in Wistar strain rats" Pharmaceutical Biology, vol. 51, no. 4, pp. 441-446, 2013.
57. M. Cekmen, A. Otunctemur, E. Ozbek et al. , "Pomegranate extract attenuates gentamicin-induced nephrotoxicity in rats by reducing oxidative stress" Renal Failure, vol. 35, no. 2, pp. 268-274, 2013.
58. M. T. Boroushaki, D. Arshadi, H. Jalili-Rasti, E. Asadpour, and A. Hosseini, "Protective effect of pomegranate seed oil against acute toxicity of diazinon in rat kidney" Iranian Journal of Pharmaceutical Research, vol. 12, no. 4, pp. 821-827, 2013.
59. M. T. Bouroshaki, H. R. Sadeghnia, M. Banihasan, and S. Yavari, "Protective effect of pomegranate seed oil on hexachlorobutadiene-induced nephrotoxicity in rat kidneys" Renal Failure, vol. 32, no. 5, pp. 612-617, 2010.
60. I. A. T. M. Meerts, C. M. Verspeek-Rip, C. A. F. Buskens et al. , "Toxicological evaluation of pomegranate seed oil" Food and Chemical Toxicology, vol. 47, no. 6, pp. 1085-1092, 2009.
61. A. Faria, R. Monteiro, N. Mateus, I. Azevedo, and C. Calhau, "Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress" European Journal of Nutrition, vol. 46, no. 5, pp. 271-278, 2007.
62. M. Pirinccoglu, G. Kizil, M. Kizil, G. Ozdemir, Z. Kanay, and M. A. Ketani, "Protective effect of Okuzgozu (Vitis vinifera L. cv. ) grape juice against carbon tetrachloride induced oxidative stress in rats" Food and Function, vol. 3, no. 6, pp. 668-673, 2012.
63. A. E. Abdel Moneim and M. F. El-Khadragy, "The potential effects of pomegranate (Punica granatum) juice on carbon tetrachloride-induced nephrotoxicity in rats" Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 359-370, 2013.
64. V. Tugcu, E. Kemahli, E. Ozbek et al. , "Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol" Journal of Endourology, vol. 22, no. 12, pp. 2723-2731, 2008.
65. J. Boateng, M. Verghese, L. Shackelford et al. , "Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats" Food and Chemical Toxicology, vol. 45, no. 5, pp. 725-732, 2007.
66. Z. M. Yazici, A. Meric, A. Midi, Y. V. ArInc, V. Kahya, and G. HafIz, "Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract" European Archives of Oto-Rhino-Laryngology, vol. 269, no. 1, pp. 45-52, 2012.
67. V. Kahya, B. Ozucer, R. Dogan et al. , "Pomegranate extract: a potential protector against aminoglycoside ototoxicity" Journal of Laryngology and Otology, vol. 128, no. 1, pp. 43-48, 2014.
68. M. Hassanpour Fard, A. E. Ghule, S. L. Bodhankar, and M. Dikshit, "Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat" Pharmaceutical Biology, vol. 49, no. 4, pp. 377-382, 2011.
69. A. Vidal, A. Fallarero, B. R. Pena et al. , "Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts" Journal of Ethnopharmacology, vol. 89, no. 2-3, pp. 295-300, 2003.
70. P. S. Negi, G. K. Jayaprakasha, and B. S. Jena, "Antioxidant and antimutagenic activities of pomegranate peel extracts" Food Chemistry, vol. 80, no. 3, pp. 393-397, 2003.
71. M. Zahin, F. Aqil, and I. Ahmad, "Broad spectrum antimutagenic activity of antioxidant active fraction of Punica granatum L. peel extracts" Mutation Research-Genetic Toxicology and Environmental Mutagenesis, vol. 703, no. 2, pp. 99-107, 2010.
72. A. de Amorim, H. R. Borba, and J. L. Armada, "Test of mutagenesis in mice treated with aqueous extracts fromPunica granatumL. (Pomegranate)" Revista Brasileira de Farmacia, vol. 76, no. 4, pp. 110-111, 1995.
73. M. C. Valadares, E. R. T. Pereira, P. L. Benfica, and J. R. Paula, "Assessment of mutagenic and antimutagenic effects of Punica granatumin mice" Brazilian Journal of Pharmaceutical Sciences, vol. 46, no. 1, pp. 121-127, 2010.
74. A. Sanchez-Lamar, G. Fonseca, J. L. Fuentes et al. , "Assessment of the genotoxic risk of Punica granatum L. (Punicaceae) whole fruit extracts" Journal of Ethnopharmacology, vol. 115, no. 3, pp. 416-422, 2008.
75. S. M. Tripathi and D. K. Singh, "Molluscicidal activity of Punica granatum bark and Canna indica root" Brazilian Journal of Medical and Biological Research, vol. 33, no. 11, pp. 1351-1355, 2000.
76. L. Ferrara, O. Schettino, P. Forgione, V. Rullo, and S. Di Gennaro, "Identification of the root of Punica granatum in galenic preparations using TLC" Bollettino della Societa Italiana di Biologia Sperimentale, vol. 65, no. 5, pp. 385-390, 1989.
77. E. P. Lansky and R. A. Newman, "Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer" Journal of Ethnopharmacology, vol. 109, no. 2, pp. 177-206, 2007.
78. S. Okonogi, C. Duangrat, S. Anuchpreeda, S. Tachakittirungrod, and S. Chowwanapoonpohn, "Comparison of antioxidant capacities and cytotoxicities of certain fruit peels" Food Chemistry, vol. 103, no. 3, pp. 839-846, 2007.
79. D. Heber, N. P. Seeram, H. Wyatt et al. , "Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size" Journal of Agricultural and Food Chemistry, vol. 55, no. 24, pp. 10050-10054, 2007.
80. M. Rosenblat, T. Hayek, and M. Aviram, "Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages" Atherosclerosis, vol. 187, no. 2, pp. 363-371, 2006.
81. M. Aviram and L. Dornfeld, "Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure" Atherosclerosis, vol. 158, no. 1, pp. 195-198, 2001.
82. M. D. Sumner, M. Elliott-Eller, G. Weidner et al. , "Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease" The American Journal of Cardiology, vol. 96, no. 6, pp. 810-814, 2005.
83. B. Cerda, C. Soto, M. D. Albaladejo et al. , "Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial" European Journal of Clinical Nutrition, vol. 60, no. 2, pp. 245-253, 2006.
84. C. P. Forest, H. Padma-Nathan, and H. R. Liker, "Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study" International Journal of Impotence Research, vol. 19, no. 6, pp. 564-567, 2007.
85. A. Basu, E. D. Newman, A. L. Bryant, T. J. Lyons, and N. M. Betts, "Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study" Journal of Nutrition and Metabolism, vol. 2013, Article ID 708381, 7 pages, 2013.
86. M. Aviram, M. Rosenblat, D. Gaitini et al. , "Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation" Clinical Nutrition, vol. 27, no. 4, p. 671, 2008.
87. T. Ismail, P. Sestili, and S. Akhtar, "Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and antiinfective effects" Journal of Ethnopharmacology, vol. 143, no. 2, pp. 397-405, 2012.
88. T. Yamamoto, K. Asakura, H. Shirasaki, and T. Himi, "Questionnaire about the intake of and hypersensitivity to fruits, vegetables and nuts including birch pollen related foods" Journal of Otolaryngology of Japan, vol. 116, no. 7, pp. 779-788, 2013.
89. B. Buyuktiryaki, B. Bartolome, U. M. Sahiner et al. , "Pomegranate allergy and pathogenesis-related protein 4" Annals of Allergy, Asthma and Immunology, vol. 111, no. 3, pp. 231-232, 2013.
90. E. Damiani, A. M. Aloia, M. G. Priore, S. Nardulli, and A. Ferrannini, "Pomegranate (Punica granatum) allergy: clinical and immunological findings" Annals of Allergy, Asthma and Immunology, vol. 103, no. 2, pp. 178-180, 2009.
91. P. Gaig, B. Bartolome, R. Lleonart, P. Garcia-Ortega, R. Palacios, and C. Richart, "Allergy to pomegranate (Punica granatum)" Allergy, vol. 54, no. 3, pp. 287-288, 1999.
92. J. M. Igea, J. Cuesta, M. Cuevas et al. , "Adverse reaction to pomegranate ingestion" Allergy, vol. 46, no. 6, pp. 472-474, 1991.
93. S. Gangemi, G. Mistrello, D. Roncarolo, S. Amato, and P. L. Minciullo, "Pomegranate-dependent exercise-induced anaphylaxis" Journal of Investigational Allergology and Clinical Immunology, vol. 18, no. 6, pp. 491-492, 2008.
94. V. L. Hegde and Y. P. Venkatesh, "Anaphylaxis to excipient mannitol: evidence for an immunoglobulin E-mediated mechanism, " Clinical and Experimental Allergy, vol. 34, no. 10, pp. 1602-1609, 2004.
95. M. Nagata, M. Hidaka, H. Sekiya et al. , "Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats" DrugMetabolism and Disposition, vol. 35, no. 2, pp. 302-305, 2007.
96. M. Hidaka, M. Okumura, K.-I. Fujita et al. , "Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats" DrugMetabolism and Disposition, vol. 33, no. 5, pp. 644-648, 2005.
97. H. Kim, Y. J. Yoon, J. H. Shon, I. J. Cha, J. G. Shin, and K. H. Liu, "Inhibitory effects of fruit juices on CYP3A activity" Drug Metabolism and Disposition, vol. 34, no. 4, pp. 521-523, 2006.
98. D. Farkas, L. E. Oleson, Y. Zhao et al. , "Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice" Journal of Clinical Pharmacology, vol. 47, no. 3, pp. 286-294, 2007.
99. A. V. Sorokin, B. Duncan, R. Panetta, and P. D. Thompson, "Rhabdomyolysis associated with pomegranate juice consumption" TheAmerican Journal of Cardiology, vol. 98, no. 5, pp. 705-706, 2006.
100. T. Khuu, A. Hickey, and M. C. Deng, "Pomegranate-containing products and tacrolimus: a potential interaction" Journal of Heart and Lung Transplantation, vol. 32, no. 2, pp. 272-274, 2013.
101. D. Farkas and D. J. Greenblatt, "Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies" Expert Opinion on Drug Metabolism and Toxicology, vol. 4, no. 4, pp. 381-393, 2008.
102. A. McCutcheon, J. Udani, and D. J. Brown, Therapeutic Monograph and Clinical Overview of POM Wonderful Pomegranate Juice, American Botanical Council, 2008.
103. E. A. Ainsworth and K. M. Gillespie, "Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent" Nature Protocols, vol. 2, no. 4, pp. 875-877, 2007.
104. K. R. Martin, C. G. Krueger, G. Rodriquez, M. Dreher, and J. D. Reed, "Development of a novel pomegranate standard and new method for the quantitative measurement of pomegranate polyphenols" Journal of the Science of Food andAgriculture, vol. 89, no. 1, pp. 157-162, 2009.
105. V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventos, "Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent, " Methods in Enzymology, vol. 299, pp. 152-178, 1998.
106. G. Borges, W. Mullen, and A. Crozier, "Comparison of the polyphenolic composition and antioxidant activity of European commercial fruit juices" Food and Function, vol. 1, no. 1, pp. 73-83, 2010.
107. U. A. Fischer, R. Carle, and D. R. Kammerer, "Identification and quantification of phenolic compounds from pomegranate (Punica granatum L. ) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn" Food Chemistry, vol. 127, no. 2, pp. 807-821, 2011.
108. U. A. Fischer, J. S. Dettmann, R. Carle, and D. R. Kammerer, "Impact of processing and storage on the phenolic profiles and contents of pomegranate (Punica granatumL. ) juices" European Food Research and Technology, vol. 233, no. 5, pp. 797-816, 2011.
109. N. Khan, F. Afaq, M. H. Kweon, K. Kim, andH. Mukhtar, "Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice" Cancer Research, vol. 67, no. 7, pp. 3475-3482, 2007.
110. M. Viladomiu, R. Hontecillas, P. Lu, and J. Bassaganya-Riera, "Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents" Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 789764, 18 pages, 2013.
111. A. Galindo, A. Calin-Sanchez, J. Collado-Gonzalez et al. , "Phytochemical and quality attributes of pomegranate fruits for juice consumption as affected by ripening stage and deficit irrigation" Journal of the Science of Food and Agriculture, vol. 94, no. 11, pp. 2259-2265, 2014.
112. M. Fischer-Zorn and V. Ara, "Granatapfelsaft-Chemische Zusammensetzung und mogliche Verfalschungen" Flussiges Obst, vol. 8, pp. 386-393, 2007.
113. A. M. Gomez-Caravaca, V. Verardo, M. Toselli, A. Segura-Carretero, A. Fernandez-Gutierrez, and M. F. Caboni, "Determination of the major phenolic compounds in pomegranate juices by HPLC-DAD-ESI-MS" Journal of Agricultural and Food Chemistry, vol. 61, no. 22, pp. 5328-5337, 2013.
114. G. A. Spanos, R. E. Wrolstad, and D. A. Heatherbell, "Influence of processing and storage on the phenolic composition of apple juice" Journal of Agricultural and Food Chemistry, vol. 38, no. 7, pp. 1572-1579, 1990.
115. B. W. Bolling, Y.-Y. Chen, and C.-Y. O. Chen, "Contributions of phenolics and added vitamin C to the antioxidant capacity of pomegranate and grape juices: synergism and antagonism among constituents" International Journal of Food Science and Technology, vol. 48, no. 12, pp. 2650-2658, 2013.
116. S. Vegara, P. Mena, N. Marti, D. Saura, and M. Valero, "Approaches to understanding the contribution of anthocyanins to the antioxidant capacity of pasteurized pomegranate juices" Food Chemistry, vol. 141, no. 3, pp. 1630-1636, 2013.
117. W. Qu, P. Li, J. Hong et al. , "Thermal stability of liquid antioxidative extracts from pomegranate peel" Journal of the Science of Food and Agriculture, vol. 94, no. 5, pp. 1005-1012, 2013.
118. U. A. Fischer, R. Carle, and D. R. Kammerer, "Thermal stability of anthocyanins and colourless phenolics in pomegranate (Punica granatum L. ) juices and model solutions" Food Chemistry, vol. 138, no. 2-3, pp. 1800-1809, 2013.
119. M. I. Gil, F. A. Tomas-Barberan, B. Hess-Pierce, D. M. Holcroft, and A. A. Kader, "Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing" Journal of Agricultural and Food Chemistry, vol. 48, no. 10, pp. 4581-4589, 2000.
120. R. Tzulker, I. Glazer, I. Bar-Ilan, D. Holland, M. Aviram, and R. Amir, "Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions" Journal of Agricultural and Food Chemistry, vol. 55, no. 23, pp. 9559-9570, 2007.
121. Y. Li, C. Guo, J. Yang, J. Wei, J. Xu, and S. Cheng, "Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract" Food Chemistry, vol. 96, no. 2, pp. 254-260, 2006.
122. H. Wasila, X. Li, L. Liu, I. Ahmad, and S. Ahmad, "Peel effects on phenolic composition, antioxidant activity, and making of pomegranate juice and wine" Journal of Food Science, vol. 78, no. 8, pp. C1166-C1172, 2013.
123. S. Madrigal-Carballo, G. Rodriguez, C. G. Krueger, M. Dreher, and J. D. Reed, "Pomegranate (Punica granatum) supplements: authenticity, antioxidant and polyphenol composition" Journal of Functional Foods, vol. 1, no. 3, pp. 324-329, 2009.
124. G. Borges and A. Crozier, "HPLC-PDA-MS fingerprinting to assess the authenticity of pomegranate beverages" Food Chemistry, vol. 135, no. 3, pp. 1863-1867, 2012.
125. F. Tezcan, S. Uzasci, G. Uyar, N. Oztekin, and F. Bedia Erim, "Determination of amino acids in pomegranate juices and fingerprint for adulteration with apple juices" Food Chemistry, vol. 141, no. 2, pp. 1187-1191, 2013.
126. S. Chrubasik and B. Roufogalis, "Bioequivalence of herbal medicines" The New Zealand Journal of Pharmaceutical, vol. 53, pp. 39-44, 2003.
127. S. U. Mertens-Talcott, P. Jilma-Stohlawetz, J. Rios, L. Hingorani, and H. Derendorf, "Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L. ) polyphenols after ingestion of a standardized extract in healthy human volunteers" Journal of Agricultural and Food Chemistry, vol. 54, no. 23, pp. 8956-8961, 2006.
128. N. P. Seeram, S. M. Henning, Y. Zhang, M. Suchard, Z. Li, andD. Heber, "Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours" Journal of Nutrition, vol. 136, no. 10, pp. 2481-2485, 2006.